CITIC Capital Partners’ $50 Million Investment in MedAlliance SA

VISCHER advised CITIC on all Swiss law matters.

Trustar Capital (formerly known as CITIC Capital Partners), a private equity affiliate of CITIC Capital Holdings Limited, has completed its over USD 50.0m investment in the Switzerland based global leading medical technology company MedAlliance SA, becoming MedAlliance’s single largest shareholder.

The investment will be used to fund the commercialization and roll-out of MedAlliance’s key product Selution SLR.

MedAlliance is a privately-owned medical technology company. It is headquartered in Nyon, Switzerland, with facilities in Irvine CA, Glasgow UK and Singapore.

MedAlliance has been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and peripheral arterial disease.

CITIC Capital Holdings Limited is an alternative investment management and advisory company. The firm manages over USD35 billion of capital through its multi-asset class platform covering private equity, real estate, structured investment & finance, asset management, and special situations. CITIC Capital has over 150 portfolio companies that span 11 sectors and employ over 800,000 people around the world.? The firm combines a deep knowledge of the Chinese business and financial markets with world-class investment expertise to create and maximize value for its investors.

The VISCHER team was led by Benedict F. Christ (Picture) and included Lukas Zuest, Aleksandra Simic, Marc Ph. Prinz, Jeannine Dehmelt, and Roland M. Mueller.

Involved fees earner: Benedict Christ – VISCHER AG; Jeannine Dehmelt – VISCHER AG; Roland Müller – VISCHER AG; Marc Prinz – VISCHER AG; Aleksandra Simic – VISCHER AG; Lukas Züst – VISCHER AG;

Law Firms: VISCHER AG;

Clients: CITIC Capital;

Author: Federica Tiefenthaler